General Info

Mannkind Corporation is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company s Technosphere Insulin System, which is in its clinical trial stages in the United States, Europe and Latin America, is a drug delivery system that facilitates the rapid delivery of active ingredients to the bloodstream via the pulmonary route. Mannkind Corporation has research and development and clinical trial capabilities to create and deliver medicines. The company maintains a clinical development and regulatory affairs facility in Paramus, N.J.